Buy Crypto Markets Spot FuturesZEC Earn Event Center Rewards Hub

Cyclerion Therapeutics, Inc. (CYCN)

NASDAQ

$4.11

$-0.12

(-2.84%)

Pre-Market

Cyclerion Therapeutics, Inc. (CYCN) Live Price Chart

Last updated: ⁦2026-09-08 09:47:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Cyclerion Therapeutics, Inc. (CYCN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $4.11, with a market capitalization of $19.90M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.03 to $8.48. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$19.90M
Open	$4.22
Day's High	$420.00
Day's Low	$1.03
Previous Close	--
Volume	1.62K
Average Volume	39.57K
P/E Ratio	--
52-Week High	$8.48
52-Week Low	$1.03
Dividend Yield	--
Earnings Date	--

Cyclerion Therapeutics, Inc. (CYCN) Pre-Market Stock Price

Cyclerion Therapeutics, Inc. (CYCN) is trading at $4.55 in pre-market trading as of 2026-09-08 09:32:00, -- from the previous close of $0.00

Pre-market trading shows how investors are pricing CYCN before the regular session opens. The current pre-market price is -- the previous close, indicating positive early trading sentiment.

Cyclerion Therapeutics, Inc. (CYCN) 7-Day Stock Price Change

Over the past seven days, Cyclerion Therapeutics, Inc. (CYCN) moved from $3.99 to $4.11, representing a gain of 2.88% ($0.12).

The stock traded between $3.55 and $5.19 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.

The average daily volume was 116.47 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

CYCN 52-Week Price Position

Position in Range: 41.3%

52W Low$1.03

52W High$8.48

CYCN is currently trading at $4.11, placing it 41.3% of the way from its 52-week low of $1.03 to its 52-week high of $8.48. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Cyclerion Therapeutics, Inc. (CYCN)?

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. The company focuses on enabling the full therapeutic potential of next-generation sGC stimulators and neuropsychiatric diseases. Its pipeline products include Olinciguat, Praliciguat, and others.

Cyclerion Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	1
Exchange	NASDAQ
Company Website	https://www.cyclerion.com

How to Buy Cyclerion Therapeutics, Inc. (CYCN) Stock on MEXC

Eligible investors can buy real shares of Cyclerion Therapeutics, Inc. (CYCN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CYCN and Place Your Order

Open the RealStocks trading page and search for CYCN. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Cyclerion Therapeutics, Inc. (CYCN) stock price today?

Cyclerion Therapeutics, Inc. (CYCN) is currently trading at $ 4.11, -- from the previous close of --. Intraday prices update in real time during regular trading hours.

2.Is CYCN stock going up or down today?

As of 2026-09-08 09:32:00, CYCN is trading at $ 4.11, -- from its previous close of --. The stock has traded between $ 1.03 and $ 420.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is CYCN pre-market price?

As of 2026-09-08 09:32:00, CYCN is trading at $ 4.55 in pre-market trading, -- from the previous close of --. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CYCN after-hours price?

As of 2026-09-08 09:32:00, CYCN is trading at $ 4.23 in after-hours trading, -- from the regular-session close of --. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is CYCN stock trading now?

CYCN trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CYCN sit relative to its 52-week high and low?

Over the past 52 weeks, CYCN has traded between a low of $ 1.03 and a high of $ 8.48. At $ 4.11, the stock is positioned 41.3% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Cyclerion Therapeutics, Inc. in?

Cyclerion Therapeutics, Inc. (CYCN) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Cyclerion Therapeutics, Inc.'s market capitalization and where is it listed?

Cyclerion Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 19.90M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CYCN valued in terms of P/E ratio and EPS?

CYCN trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Cyclerion Therapeutics, Inc. pay a dividend?

Cyclerion Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.